Adjuvant Treatment of Stage I-II Serous Endometrial Cancer: A Single Institution 20-Year Experience.

Aquila Akingbade, François Fabi, Rodrigo Cartes, James Tsui, Joanne Alfieri

Abstract read

In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aquila AkingbadeDivision of Radiation Oncology, London Health Sciences Center, Western University, London, ON N6A 5W9, Canada.ORCID 0000-0003-3271-2208

François FabiRadiation Oncology Service, Centre Intégré de Cancérologie (CIC), Hôpital de l'Enfant-Jésus, Centre Hospitalier Universitaire de Québec, Québec, QC G1J 1Z4, Canada.

Rodrigo CartesDivision of Radiation Oncology, McGill University Health Center, Montreal, QC H4A 3J1, Canada.

James TsuiDivision of Radiation Oncology, McGill University Health Center, Montreal, QC H4A 3J1, Canada.

Joanne AlfieriDivision of Radiation Oncology, McGill University Health Center, Montreal, QC H4A 3J1, Canada.ORCID 0000-0002-3829-9250

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Endometrial NeoplasmsNeoplasm StagingAdultAgedAged, 80 and overChemoradiotherapy, AdjuvantChemotherapy, AdjuvantCystadenocarcinoma, SerousFemaleHumansHysterectomyMiddle AgedRadiotherapy, AdjuvantRetrospective Studiesadjuvant therapyearly-stageserous endometrial cancer

Identifiers

PMID39057149

DOI10.3390/curroncol31070277

PMCPMC11276548

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.